Application of machine learning to improve the results of high-throughput docking against the HIV-1 protease

Anthony E Klon1, Meir Glick, John W Davies

  • 1Lead Discovery Center, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA. anthony.klon@pharma.novartis.com

Journal of Chemical Information and Computer Sciences
|November 24, 2004
PubMed